Gene expression profiling of ERBB receptors and ligands in human transitional cell carcinoma of the bladder

Journal of Urology

Volumn 175, Issue 3, 2006, Pages 1127-1132

  Amsellem Ouazana, Delphine ^a   Bièche, Ivan ^b   Tozlu, Senguül ^b   Botto, Henry ^c   Debré, Bernard ^a   Lidereau, Rosette ^b  

^a Hôpital Cochin ^*  (France)

^b CENTRE RENÉ HUGUENIN   (France)

^c FOCH HOSPITAL   (France)

Author keywords

bladder; bladder neoplasms; carcinoma; erbB; gene expression profiling; genes; transitional cell

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; LIGAND; MESSENGER RNA; OLIGONUCLEOTIDE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER TUMOR; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; TRANSITIONAL CELL CARCINOMA;

EID: 32044446724     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00317-4     Document Type: Article

References (20)

1. Y. Yarden, M.X. Sliwkowski Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 2001 127
2. L. Strachan, J.G. Murison, R.L. Prestidge, M.A. Sleeman, J.D. Watson, K.D. Kumble Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily J Biol Chem 276 2001 18265
3. J.S. de Bono, E.K. Rowinsky The ErbB receptor family a therapeutic target for cancer Trends Mol Med 8 2002 S19
4. S. Al-Sukhun, M. Hussain Molecular biology of transitional cell carcinoma Crit Rev Oncol Hematol 47 2003 181
5. M.L. Quek, D.I. Quinn, S. Daneshmand, J.P. Stein Molecular prognostication in bladder cancer-a current perspective Eur J Cancer 39 2003 1501
6. J. Bellmunt, M. Hussain, C.P. Dinney Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family Crit Rev Oncol Hematol 46 suppl 2003 85
7. D. Amsellem-Ouazana, P. Beuzeboc, M. Peyromaure, A. Viellefond, M. Zerbib, B. Debre Management of primary resistance to gemcitabine and cisplatin (G-C) chemotherapy in metastatic bladder cancer with HER2 over-expression Ann Oncol 15 2004 538
8. I. Bieche, P. Onody, S. Tozlu, K. Driouch, M. Vidaud, R. Lidereau Prognostic value of ERBB family mRNA expression in breast carcinomas Int J Cancer 106 2003 758
9. D.P. Wood Jr., D.D. Wartinger, V. Reuter, C. Cordon-Cardo, W.R. Fair, R.S. Chaganti DNA, RNA and immunohistochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder J Urol 146 1991 1398
10. V.B. Thogersen, B.S. Sorensen, S.S. Poulsen, T.F. Orntoft, H. Wolf, E. Nexo A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients Cancer Res 61 2001 6227
11. S. Kruger, G. Weitsch, H. Buttner, A. Matthiensen, T. Bohmer, T. Marquardt HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder prognostic implications Int J Cancer 102 2002 514
12. N.H. Chow, S.H. Chan, T.S. Tzai, C.L. Ho, H.S. Liu Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder Clin Cancer Res 7 2001 1957
13. J.K. Mellon, J. Lunec, C. Wright, C.H.W. Horne, P. Kelly, D.E. Neal c-erbB-2 in bladder cancer molecular biology, correlation with epidermal growth factor receptors and prognostic value J Urol 155 1996 321
14. R.M. Adam, T. Danciu, D.L. McLellan, J.G. Borer, J. Lin, D. Zurakowski A nuclear form of the heparin-binding epidermal growth factor-like growth factor precursor is a feature of aggressive transitional cell carcinoma Cancer Res 63 2003 484
15. J.I. Ohta, Y. Miyoshi, H. Uemura, K. Fujinami, K. Mikata, M. Hosaka Fluorescence in situ hybridization evaluation of c-erbB-2 gene amplification and chromosomal anomalies in bladder cancer Clin Cancer Res 7 2001 2463
16. C.L. Coogan, C.R. Estrada, S. Kapur, K.J. Bloom HER-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder Urology 63 2004 786
17. I. Bieche, P. Onody, I. Laurendeau, M. Olivi, D. Vidaud, R. Lidereau Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications Clin Chem 45 1999 1148
18. T.T. Junttila, M. Laato, T. Vahlberg, K.O. Soderstrom, T. Visakorpi, J. Isola Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients Clin Cancer Res 9 2003 5346
19. A.A. Memon, B.S. Sorensen, P. Melgard, L. Fokdal, T. Thykjaer, E. Nexo Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients Br J Cancer 91 2004 2034
20. V.B. Thogersen, P.E. Jorgensen, B.S. Sorensen, P. Bross, T. Orntoft, H. Wolf Expression of transforming growth factor alpha and epidermal growth factor receptor in human bladder cancer Scand J Clin Lab Invest 59 1999 267